In conclusion, our study revealed for the first time an entirely new regulatory mechanism of MAPK activation, revealing that TRIM22, which is highly expressed in GBM, regulates the activation of MAPK signaling by both direct (E3 ubiquitin ligase) and indirect (transcription factor) means. The gene discussed is TRIM22; the disease is glioblastoma.